• TDAAC was initially established from a grant awarded to VCU in 2001 by the Virginia Commonwealth Technology Research Fund (CTRF). It represents a close collaboration within and between multiple disciplines and departments within VCUHS including the Massey Cancer Center and Departments of Pathology, Surgery, and Internal Medicine.
Collect human residual tumor and hematopoietic samples for IRB approved studies
• Can include additional collection requirements specified by an IRB approved protocol
• Coordinate specimen acquisition and handling with requirements for histopathological review for patient care
Assure rapid collection and handling of tissue to maximize RNA integrity
• Patients are consented prior to the use of their tissue in any TDAAC related study
• Collect primary data on new cancer patients including patient history surveys
• Process hematopoietic samples, including bone marrow aspirates and peripheral blood samples, separating  plasma and cryopreserving mononuclear cells

continued >>